GlassScriptPhysician profile
Albert C Mu
NPI 1205001559
$1,517.23
in general payments reported to CMS, 2019-2025
31 companies · $36.52 in 2025
The $36.52 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,076 · 2020: $96.20 · 2021: $169 · 2022: $35.96 · 2023: $30.38 · 2024: $73.14 · 2025: $36.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $216.85 | 2019-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $179.17 | 2019-2020 | |
| Astellas Pharma US INC | $167.58 | 2019 | |
| Amgen INC. | $131.94 | 2019 | |
| Janssen Pharmaceuticals, INC | $111.01 | 2019-2020 | |
| Boston Scientific Corporation | $71.05 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.04 | 2019 | |
| Abbvie INC. | $53.61 | 2019 | |
| Pfizer INC. | $46.62 | 2019-2025 | |
| Novo Nordisk INC | $44.88 | 2019 | |
| Dermira, INC. | $34.21 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.11 | 2019 | |
| Allergan, INC. | $28.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.99 | 2019 | |
| Lilly USA, LLC | $24.82 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $23.73 | 2024 | Recorlev |
| Advanced Respiratory, INC | $23.24 | 2020 | |
| Amarin Pharma, INC. | $21.28 | 2019 | |
| Genentech USA, INC. | $20.39 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.22 | 2019 | |
| Inspire Medical Systems, INC. | $19.60 | 2024 | Inspire |
| Coloplast Corp | $18.23 | 2022 | |
| Becton, Dickinson and Company | $18.03 | 2025 | Rotarexs 6 F X 135 Cm |
| Medtronic, INC. | $16.29 | 2023 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.73 | 2024 | Xifaxan, Trulance |
| Sanofi Pasteur INC. | $15.57 | 2019 | |
| Hologic Sales and Service, LLC | $15.40 | 2021 | |
| Abbott Laboratories | $15.23 | 2019 | |
| Horizon Therapeutics Plc | $15.14 | 2019 | |
| Radius Health, INC. | $14.03 | 2019 | |
| Merck Sharp & Dohme LLC | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Mu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.